S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. (Q55033177)

16 June 2018

title

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. (English)

1 reference

16 June 2018

multicenter clinical trial

0 references

1 reference

1 reference

alcoholic liver cirrhosis

litr

1 reference

5

1 reference

16 June 2018

Albert Pares

16

1 reference

16 June 2018

author name string

Mato JM

1

1 reference

16 June 2018

Cámara J

2

1 reference

16 June 2018

Fernández de Paz J

3

1 reference

16 June 2018

Caballería L

4

1 reference

16 June 2018

Caballero A

6

1 reference

16 June 2018

García-Buey L

7

1 reference

16 June 2018

Beltrán J

8

1 reference

16 June 2018

Benita V

9

1 reference

16 June 2018

Caballería J

10

1 reference

16 June 2018

Solà R

11

1 reference

16 June 2018

Moreno-Otero R

12

1 reference

16 June 2018

Barrao F

13

1 reference

16 June 2018

Martín-Duce A

14

1 reference

16 June 2018

Correa JA

15

1 reference

16 June 2018

Barrao E

17

1 reference

16 June 2018

García-Magaz I

18

1 reference

16 June 2018

Puerta JL

19

1 reference

16 June 2018

Moreno J

20

1 reference

16 June 2018

Boissard G

21

1 reference

16 June 2018

Ortiz P

22

1 reference

16 June 2018

Rodés J

23

1 reference

16 June 2018

publication date

1 June 1999

1 reference

16 June 2018

published in

Journal of Hepatology

1 reference

16 June 2018

volume

30

1 reference

16 June 2018

issue

6

1 reference

16 June 2018

page(s)

1081-1089

1 reference

16 June 2018

Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Labile methyl balances for normal humans on various dietary regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Expression of rat liver S-adenosylmethionine synthetase in Escherichia coli results in two active oligomeric forms

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Hypermethioninemia associated with methionine adenosyltransferase deficiency: Clinical, morphologic, and biochemical observations on four patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Interaction of liver methionine adenosyltransferase with hydroxyl radical

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Rate of Disappearance From Plasma of Intravenously Administered Methionine in Patients With Liver Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Protective role of S-adenosyl-l-methionine against acetaminophen induced mortality and hepatotoxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

S-adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Protective role of S-adenosyl-L-methionine on liver injury induced by D-galactosamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Inhibition by ethanol of rat liver plasma membrane (Na+,K+)ATPase: protective effect of S-adenosyl-L-methionine, L-methionine, and N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Evidence that S-adenosylmethionine and N-acetylcysteine reduce injury from sequential cold and warm ischemia in the isolated perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

S-adenosyl-L-methionine protection against alpha-naphthylisothiocyanate-induced cholestasis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Effect of S-adenosyl-L-methionine on thioacetamide-induced liver damage in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Is colchicine effective therapy for cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Defective methionine metabolism in cirrhosis: relation to severity of liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

Treatment of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980263-3

7 January 2021

10.1016/S0168-8278(99)80263-3

Identifiers

DOI

1 reference

16 June 2018

1 reference

16 June 2018